About AcuityBio
AcuityBio is a company based in Brookline (United States) founded in 2008. AcuityBio has raised $2.63 million across 4 funding rounds from investors including HHS. AcuityBio operates in a competitive market with competitors including TriSalus Life Sciences, Luminate Medical, Cooler Heads, Delcath and Cognos Therapeutics, among others.
- Headquarter Brookline, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$2.63 M (USD)
in 4 rounds
-
Latest Funding Round
$175 K (USD), Series A
Feb 10, 2020
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of AcuityBio
AcuityBio has successfully raised a total of $2.63M across 4 strategic funding rounds. The most recent funding activity was a Series A round of $175 thousand completed in February 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in AcuityBio
AcuityBio has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include HHS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Public health and human services are overseen by HHS.
|
Locked | Locked | Locked |
Investor details for AcuityBio
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by AcuityBio
Investment portfolio details for AcuityBio
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - AcuityBio
Detailed financials for AcuityBio
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Acuitybio Comparisons
Peer comparison for AcuityBio
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of AcuityBio
AcuityBio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as TriSalus Life Sciences, Luminate Medical, Cooler Heads, Delcath and Cognos Therapeutics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of drug delivery devices to treat cancers
|
|
| Locked | Locked | Locked |
Developer of a medical device to prevent hair loss during chemotherapy
|
|
| Locked | Locked | Locked |
Developer of cold cap system to prevent chemotherapy side effects
|
|
| Locked | Locked | Locked |
Delcath Systems, Inc. is focused on liver cancer treatments.
|
|
| Locked | Locked | Locked |
Cognos Therapeutics is focused on innovative neurological and oncological treatments.
|
|
| Locked | Locked | Locked |
UK-based biotherapeutics company developing products for the treatment of liver and HCC cancer.
|
Detailed competitors of AcuityBio
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Acuitybio
Complete news archive for AcuityBio
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about AcuityBio
AcuityBio was founded in 2008.
AcuityBio is headquartered in Brookline, United States. It is registered at Brookline, Massachusetts, United States.
AcuityBio is a funded company, having raised a total of $2.63M across 4 funding rounds to date.
AcuityBio was founded in 2008 and is based in Brookline, United States. A bio-compatible, biodegradable surgical implant is being developed in the medical device sector to address lung cancer. Therapeutic drugs are delivered locally to the surgical site over several months, aiming to reduce recurrence rates. Operations focus on implant design and drug-elution technology for oncology applications.
AcuityBio's top competitors include TriSalus Life Sciences, Cooler Heads and Cognos Therapeutics.
AcuityBio has 1 investor. Key investors include HHS.